Sign in

CIK 0001372299

  • Non-accelerated filer
  • Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
  1. 4 Open-market sale Director sold 7,500 shares at $4.07 ($30,525)
  2. 4 Grant or award Chief Financial Officer acquired 125,534 shares (grant or award)
  3. 4 Grant or award Chief Executive Officer acquired 346,540 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 3/A Insider 3/A
  6. 4 Exercise or conversion Director acquired 45,000 shares (option exercise)
  7. 4 Open-market sale Chief Executive Officer sold 115,000 shares at $5.22 ($600,300)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Option exercise Director acquired 145,473 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Chief Executive Officer sold 115,000 shares at $8.04 ($924,600)
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale Director sold 150,300 shares at $17.32 ($2,603,196)
  17. 4 Open-market sale Director sold 50,000 shares at an average $15.03 ($751,500)
  18. 4 Open-market sale Chief Executive Officer sold 115,367 shares at $14.15 ($1,632,443)
  19. 4 Open-market sale Director sold 63,429 shares at $15.07 ($955,875)
  20. 4 Open-market sale Director sold 15,000 shares at $15.00 ($225,000)

Page 5 of 15 · 288 filings